Victory Capital Management
GRTX

Victory Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Victory Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,970
Closed -$28K – 3408
2020
Q1 		$28K Buy
+2,970
New +$38.3K ﹤0.01% 2991

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management's GRTX Position: Q2 2020 in Review

Victory Capital Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2020, closing a stake of 2,970 shares — an estimated $28K sold.

Victory Capital Management first reported a position in GRTX in Q1 2020 and held it in 1 quarter. The position peaked at $28K in Q1 2020. 41 funds tracked by Wall St. Rank hold GRTX as of Q2 2020.

  • Victory Capital Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,970 Galera Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $28K.
  • Victory Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Victory Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $28K in Q1 2020.
  • 41 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.